High dose idarubicine, busulphan and melphalan conditioning regimen for lymphoproliferative disorders

被引：0
|
作者：
Trasarti, S [1 ]
Meloni, G [1 ]
Capria, S [1 ]
Bongarzoni, V [1 ]
Ferrazza, G [1 ]
Iodice, F [1 ]
Proia, A [1 ]
Trisolini, SM [1 ]
Mandelli, F [1 ]
机构：
[1] Univ Rome La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Roma, Italy
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
352
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 50 条
  • [21] Velcade and high dose melphalan: A new preparative regimen
    Roussel, M.
    Danho, C.
    Huynh, A.
    Attal, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 193 - 193
  • [22] Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Rodriguez, Tulio E.
    Hari, Parameswaran
    Stiff, Patrick J.
    Smith, Scott E.
    Sterrenberg, Danielle
    Vesole, David H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (08) : 1391 - 1396
  • [23] Busulphan and melphalan: A novel autograft conditioning regime in multiple myeloma.
    Clark, A
    Mitchell, L
    Alcorn, M
    Tansey, P
    Cook, G
    Franklin, IM
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 100 - 100
  • [24] Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen with Methotrexate-Based GvHD Prophylaxis
    On, Sandy
    Domingo, Walter
    Cheung, Edna
    Johnston, Laura
    BLOOD, 2023, 142
  • [25] Final Report of a Phase I Study of Clofarabine Plus High Dose Melphalan as a Conditioning Regimen for Allogeneic Transplantation
    Kirschbaum, Mark
    Stein, Anthony Selwyn
    Frankel, Paul
    Popplewell, Leslie
    Chen, Robert W.
    Delioukina, Maria L.
    Nakamura, Ryotaro
    Snyder, David S.
    Slape, Cynthia
    Ruel, Christopher
    Conrad, Joel
    Nademanee, Auaypom
    Forman, Stephen
    BLOOD, 2010, 116 (21) : 235 - 235
  • [26] Autologous stem cell transplantation with high dose melphalan conditioning regimen is safe for elderly multiple myeloma patients
    Czyz, Anna
    Szeremet, Agnieszka
    Bogucka-Fedorczuk, Aleksandra
    Majcherek, Maciej
    Rybka, Justyna
    Prajs, Iwona
    Wrobel, Tomasz
    BONE MARROW TRANSPLANTATION, 2019, 54 : 499 - 500
  • [27] Intravenous Busulphan in Combination with ETOPOSIDE and MELPHALAN Used as Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Lymphomas: Evaluation of Toxicity and Efficacy
    Mallouri, Despina
    Sakellari, Ioanna
    Batsis, Ioannis
    Konstantinou, Varnavas
    Baliakas, Panayotis
    Antoniou, Athanasios
    Apostolou, Chrisa
    Anagnostopoulos, Achilles
    Fassas, Athanasios
    BLOOD, 2010, 116 (21) : 567 - 567
  • [28] Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow up of a Novel Conditioning Regimen
    Hagen, Patrick
    D'Souza, Anita
    Hari, Parameswaran
    Davila, Omar
    Zhang, Mei-Jie
    Vesole, David H.
    Smith, Scott E.
    Rodriguez, Tulio E.
    Stiff, Patrick J.
    BLOOD, 2019, 134
  • [29] Comparison of conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High-dose melphalan versus high-dose melphalan and bortezomib
    Aypar, Eda
    Izzettin, Fikret Vehbi
    Aki, Sahika Zeynep
    Sancar, Mesut
    Yegin, Zeynep Arzu
    Turkoz-Sucak, Gulsan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (04) : 281 - 289
  • [30] Autologous Stem Cell Transplantation with Moderate Dose of Idarubicin and Busulphan as Conditioning Regimen in Acute Myelogenous Leukemia
    Mashhadi, M. A.
    Ramzi, M.
    Alimoghaddam, K.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2008, 10 (03) : 202 - 207
12345